IP Library › Granted Patent US 12,544,497
Granted Patent B2
US 12,544,497 · App. 17/814,541 · Granted Feb 10, 2026

Method of operation utilizing electric field for processing of blood to neutralize pathogen cells therein

Inventors: William M. Gosney (Lucas, TX); Dale B. Nixon (Dallas, TX)
A61M1/36A61L2/0011A61L2/24A61L2202/11A61L2202/14A61L2202/22A61M2205/12A61M2205/3306
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,544,497
App. No.
17/814,541
Granted
Feb 10, 2026
Kind
B2
Abstract

An operational unit for locating and neutralizing pathogen cells in blood includes a time use cassette which has a plurality of thin holding chambers that are filled with blood drawn from a patient. A light source illuminates each of the holding chambers and passes light to an underlying sensor array such that the cells in the blood selectively block the light to produce shadow images of the cells in the sensor array. A processor performs pattern recognition to identify and locate the pathogen cells by use of an image library. After the pathogen cells are located, an electric field is activated in the cassette chamber areas that include the identified pathogen cells. Sufficient electric field energy is applied to destroy the identified pathogen cells. A pump refills the cassette holding chambers, returns the neutralized-pathogen blood to the patient, and the process is repeated for a period of time.

Claims (65)

1 . A method for the treatment of blood which has cells therein including pathogen cells, comprising the steps of:

(a) filling a chamber with said blood, said chamber having opposed parallel transparent walls and an array of locations therein,

(b) directing collimated light through said walls of said chamber,

(c) receiving a least a portion of said collimated light which has passed through said chamber by a light sensor which has an array of light sensitive pixels,

(d) producing a sensor image by said light sensor, said sensor image including shadow images therein produced by cells in said chamber which at least partially block the passage of said collimated light through said chamber,

(e) comparing said shadow images in said sensor image to reference images of said pathogen cells to identify ones of said shadow images which substantially match one or more of said pathogen cell reference images,

(f) determining the locations within said array of locations in said chamber of pathogen cells therein which produced the identified ones of said shadow images, and

(g) concurrently applying an electric field at each of a plurality of said pathogen cell determined locations in said chambers.

2 . The method as recited in claim 1 including the steps of:

removing the blood from said chamber,

filling said chamber with said blood concurrently with said step of removing the blood from said chamber, and

repeating steps (b), (c), (d), (e), (f) and (g).

3 . The method as recited in claim 1 wherein the step of applying an electric field at a plurality of said determined locations in said chambers includes a step of applying a voltage differential between pairs of orthogonal electrically conductive lines, each line of said pair proximate one of said opposed walls of said chamber, and each said pair of orthogonal lines cross at a one of said determined locations.

4 . The method as recited in claim 1 wherein the step of directing collimated light includes directing a least a portion of said collimated light through a group of electrically conductive lines into said chamber.

5 . The method as recited in claim 1 including a step of emptying said blood out of said chamber after the step of concurrently applying an electric field at a plurality of said pathogen cell determined locations in said chamber.

6 . The method as recited in claim 1 wherein a plurality of said determined locations each includes a location correction factor.

7 . The method as recited in claim 1 including a step of converting light into electrical power for producing said electric fields.

8 . The method as recited in claim 1 wherein the following steps are performed before steps (a) through (g):

(1) filling said chamber with blood,

(2) directing collimated light through said walls of said chamber,

(3) receiving said collimated light, which has passed through said chamber, by said light sensor,

(4) producing a reference sensor image by said light sensor in response to receiving said collimated light, said reference sensor image having therein a plurality of shadow images produced by cells in said chamber, and

(5) selecting in said reference sensor image said ones of said shadow images to comprise said reference images.

9 . The method as recited in claim 1 wherein each of said electrical fields is produced between a pair of orthogonal electrically conductive lines.

10 . A method for the treatment of blood which has cells therein, including pathogen cells, comprising the steps of:

(a) filling a plurality of chambers with said blood, each said chamber having opposed parallel transparent walls,

(b) directing collimated light through said walls of said chambers including directing a least a portion of said light through electrically conductive lines,

(c) receiving at least a portion of said collimated light which has passed through each said chamber by a respective light sensor which light sensor has an array of light sensitive pixels,

(d) producing a sensor image by each of said light sensors, each said sensor image including shadow images therein produced by cells in said corresponding chamber, said cells which at least partially block the passage of said collimated light through the corresponding said chamber,

(e) comparing the shadow images in said sensor images to reference images of said pathogen cells to identify shadow images which substantially match one or more of said pathogen cell reference images,

(f) determining the locations in said chambers of the pathogen cells therein which produced the identified shadow images, and

(g) applying an electric field at each of a plurality of said determined locations in said chambers.

11 . The method as recited in claim 10 including the steps of:

concurrently removing the blood previously filled into said chambers from said chambers after steps (a) through (g) have been completed,

filling said chambers with said blood concurrently with said step of removing the blood from the chambers, and

repeating steps (b), (c), (d), (e), (f) and (g).

12 . The method as recited in claim 10 wherein said electrically conductive lines include a first set of parallel electrically conductive lines on one side of each said chamber and a second set of parallel electrically conductive lines on a second side of each said chamber.

13 . The method as recited in claim 10 wherein each of said electric fields is produced between a pair of said electrically conductive lines, the lines within each pair of said lines being orthogonal to each other.

14 . The method as recited in claim 10 wherein each said electric field is produced between a pair of said electrically conductive lines, the lines within each said pair located on opposite sides of the corresponding chamber.

15 . The method as recited in claim 10 wherein a plurality of said electric fields applied at said determined locations are applied concurrently within said chambers.

16 . A method for the treatment of blood which has cells therein, including pathogen cells, comprising the steps of:

(a) producing a continuous flow of said blood,

(b) directing said flow of blood to fill a plurality of first chambers with said blood and then holding said blood in said first chambers in a static state, each said first chamber having opposed parallel transparent walls,

(c) directing collimated light through said walls of said first chambers including directing at least a portion of said light directed to said first chambers through a first set of electrically conductive lines,

(d) receiving a least a portion of said collimated light which has passed through said first chambers by a plurality of respective first chamber light sensors, each said first chamber light sensor having an array of light sensitive pixels,

(e) producing a first chamber sensor image by each of said first chamber light sensors, said first chamber sensor images including shadow images therein produced by cells in said first chambers which cells at least partially block the passage of said collimated light through said first chambers,

(f) comparing the shadow images in said first chamber sensor images to reference images of said pathogen cells to identify shadow images which substantially match one or more of said reference images of said pathogen cells,

(g) determining the locations in each of said first chambers of the pathogen cells therein which produced said identified shadow images,

(h) applying an electric field at said determined locations in said first chambers to neutralize a plurality of the pathogen cells located at the determined locations,

(i) directing said continuous flow of blood into a plurality of second chambers after completion of said step of directing said flow of blood to fill a plurality of first chambers with said blood,

(j) directing collimated light through said walls of said second chambers including directing at least a portion of said light directed to said second chambers through a second set of electrically conductive lines,

(k) receiving a least a portion of said collimated light which has passed through said second chambers by a plurality of respective second chamber light sensors, each said second chamber light sensor having an array of light sensitive pixels,

(l) producing a second chamber sensor image by each of said second chamber light sensors, said second chamber sensor images including shadow images therein produced by cells in said second chambers which cells at least partially block the passage of said collimated light through said second chambers,

(m) comparing the shadow images in said second chamber sensor images to said reference images of said pathogen cells to identify shadow images which substantially match one or more reference images of said pathogen cells,

(n) determining the locations in each of said second chambers of the pathogen cells therein which produced the identified shadow images, and

(o) applying an electric field at a plurality of said determined locations in said second chambers.

17 . The method as recited in claim 16 including the step of receiving light and generating electric power from said received light and using said generated electric power to produce said electric fields.

18 . The method as recited in claim 16 wherein a plurality of said electric fields applied in said first chambers are applied concurrently and a plurality of said electric fields applied in said second chambers are applied concurrently.

19 . The method as recited in claim 16 wherein each of said electric fields is produced by a pair of orthogonally positioned ones of said electrically conductive lines.

20 . The method as recited in claim 16 wherein the following steps are performed before steps (a) through (o):

(1) filling at least a selected one of said chambers with blood,

(2) directing collimated light through said walls of said selected one chamber,

(3) receiving said collimated light, which has passed through said selected one chamber, by a corresponding one of said corresponding light sensors,

(4) producing a reference sensor image by said corresponding light sensor in response to receiving said collimated light, said reference sensor image having therein a plurality of shadow images produced by cells in said chamber, and

(5) selecting in said reference sensor image ones of said shadow images to comprise said reference images.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2025
From: GOSNEY, WILLIAM MILTON, MR.; NIXON, DALE BRUCE
To: BLOOD IMAGE TECHNOLOGY LLC
Reel/Frame 070194/0538 →
Continuity (1)
Related Publication 20240024550A1 · Jan 25, 2024
References Cited (73)
US 4786812A · Humphreys · 1988 [cited by applicant]
US 5035693A · Kratzer et al. · 1991 [cited by applicant]
US 6127507A · Santerre · 2000 [cited by applicant]
US 6584217B1 · Lawless · 2003 [cited by applicant]
US 6746613B2 · Korenev · 2004 [cited by applicant]
US 6872198B1 · Wilson et al. · 2005 [cited by applicant]
US 6998076B2 · Ohshiro · 2006 [cited by applicant]
US 7112916B2 · Goh et al. · 2006 [cited by applicant]
US 7229427B2 · Mallett et al. · 2007 [cited by applicant]
US 7346205B2 · Walker, Jr. · 2008 [cited by applicant]
US 7669980B2 · Silverbrook · 2010 [cited by applicant]
US 7758208B2 · Bailey · 2010 [cited by applicant]
US 7837897B2 · Zhang et al. · 2010 [cited by applicant]
US 7889154B2 · Araki et al. · 2011 [cited by applicant]
US 8242832B2 · Ochi et al. · 2012 [cited by applicant]
US 8258899B2 · Feng et al. · 2012 [cited by applicant]
US 8496606B2 · Leonard · 2013 [cited by applicant]
US 8624968B1 · Hersee et al. · 2014 [cited by applicant]
US 9141885B2 · Yang et al. · 2015 [cited by applicant]
US 9387286B2 · Kelly et al. · 2016 [cited by applicant]
US 9420209B2 · Ahn et al. · 2016 [cited by applicant]
US 9569664B2 · Judkewitz et al. · 2017 [cited by applicant]
US 9574989B2 · Lei · 2017 [cited by applicant]
US 9643184B2 · Zeng et al. · 2017 [cited by applicant]
US 10179896B2 · Baker · 2019 [cited by applicant]
US 10300188B2 · Joos et al. · 2019 [cited by applicant]
US 10641698B2 · Shi et al. · 2020 [cited by applicant]
US 11253858B2 · Sherman et al. · 2022 [cited by applicant]
US 20020076744A1 · Koller · 2002 [cited by applicant]
US 20020182241A1 · Borenstein · 2002 [cited by applicant]
US 20030060747A1 · Fries · 2003 [cited by applicant]
US 20030153825A1 · Mooradian · 2003 [cited by applicant]
US 20040022669A1 · Ruan et al. · 2004 [cited by applicant]
US 20050063872A1 · Foster · 2005 [cited by applicant]
US 20050105077A1 · Padmanabham · 2005 [cited by applicant]
US 20060058167A1 · Ragusa et al. · 2006 [cited by applicant]
US 20080099406A1 · Ruan et al. · 2008 [cited by applicant]
US 20090316972A1 · Borenstein · 2009 [cited by applicant]
US 20110021966A1 · Leonard · 2011 [cited by applicant]
US 20110071465A1 · Wang · 2011 [cited by applicant]
US 20110200655A1 · Black · 2011 [cited by examiner]
US 20120223217A1 · Zheng et al. · 2012 [cited by applicant]
US 20130178834A1 · Greenberg et al. · 2013 [cited by applicant]
US 20130190212A1 · Handique · 2013 [cited by applicant]
US 20140193799A1 · Borenstein · 2014 [cited by applicant]
US 20150083596A1 · Hester · 2015 [cited by applicant]
US 20150293012A1 · Rapaport et al. · 2015 [cited by applicant]
US 20160041094A1 · Lei · 2016 [cited by examiner]
US 20160058937A1 · Gaitas et al. · 2016 [cited by applicant]
US 20160106873A1 · Dobrinsky · 2016 [cited by applicant]
US 20160171686A1 · Du · 2016 [cited by applicant]
US 20160220961A1 · DiBiasio · 2016 [cited by applicant]
US 20170021042A1 · Dodd et al. · 2017 [cited by applicant]
US 20170049889A1 · Felder et al. · 2017 [cited by applicant]
US 20170067007A1 · Miltenyl · 2017 [cited by applicant]
US 20180066219A1 · Borenstein · 2018 [cited by applicant]
US 20180078641A1 · Felder et al. · 2018 [cited by applicant]
US 20190099543A1 · Sasaki · 2019 [cited by applicant]
US 20200179586A1 · Spearman · 2020 [cited by applicant]
US 20200179929A1 · Sherman · 2020 [cited by applicant]
US 20200200729A1 · Sherman et al. · 2020 [cited by applicant]
US 20200232983A1 · Miller et al. · 2020 [cited by applicant]
US 20200256889A1 · Fine · 2020 [cited by applicant]
US 20200289819A1 · Srimathveeravalli et al. · 2020 [cited by applicant]
US 20200305783A1 · Baker · 2020 [cited by applicant]
US 20200346211A1 · Juncker et al. · 2020 [cited by applicant]
US 20210333211A1 · Chen et al. · 2021 [cited by applicant]
US 20210364511A1 · Yu et al. · 2021 [cited by applicant]
US 20210398296A1 · Fang et al. · 2021 [cited by applicant]
US 20220012456A1 · Knowles · 2022 [cited by applicant]
US 20220032302A1 · Ohman · 2022 [cited by applicant]
DE 102018003533A1 · 2019 [cited by examiner]
KR 101485336B1 · 2015 [cited by applicant]